11 December 2024
Eden
Research
("Eden"
or "the Company")
Mevalone® included in Organic
Input List by FiBL Germany
Eden Research plc (AIM: EDEN), a
leader in sustainable biopesticide and biocontrol products, is
pleased to announce that its flagship fungicide, Mevalone®, has
been registered as an input for organic farming in
Germany.
The Input List for organic production
in Germany is managed by the Research Institute of Organic
Agriculture, FiBL, a European organisation with presence in several
countries and with well-recognised and respected activities related
to sustainability and organic farming. This inclusion has been
granted by experts who evaluate farming inputs for their compliance
with the requirements of organic production in Germany and multiple
other countries.
The news follows the approval of
Mevalone in Germany, announced in August 2024. Eden's German
commercial partner, Sumi Agro Deutschland, which has a strong focus
on supporting organic farmers, has reinforced the importance of
having this registration by FiBL Germany to better address the
needs of organic growers in Germany.
The registration for organic farming
follows the German 2030 Organic Strategy that was released in
November 2023. The German 2030 Organic Strategy, developed by the
Federal Ministry of Food and Agriculture, outlines 30 measures the
country will take with the aim of reaching 30% of organic farmland
in Germany by 20301. This policy exceeds the 25% of
organic farmland in the EU as set in the EU Green Deal and means
that significant action is required by the entire agriculture
sector to reach this goal. Therefore, the registration of Mevalone
as an input for organic farming in Germany positions the product as
a significant contributor to support German farmers to achieve
their targets whilst also retaining productivity.
With FiBL Germany's addition of
Mevalone to the Organic Input list, Eden expects its flagship
fungicide to become an even more versatile product used by German
organic growers to effectively control fungal diseases and to avoid
production loss, whilst also remaining consistent with the
requirements of organic agriculture.
Sean
Smith, Chief Executive Officer of Eden Research plc,
commented:
"Mevalone's inclusion in the Organic
Input List by FiBL Germany provides us with another vital organic
registration in an important market, following in the footsteps of
Greece, Italy, and France. Our products' organic compliance
demonstrates their sustainable qualities based on Eden's terpene
chemistry, as well as their strong efficacy, even when compared
with conventional pesticides.
"Germany currently has approximately
10% of apple orchards and 15% of vineyard areas dedicated to
organic farming, and indications show that these proportions of
organic farmland are growing rapidly. Against this backdrop, we
have strategically positioned Mevalone as one of the leading
alternative fungicide products that fits both the conventional and
organic farming needs."
1Federal
Ministry of Food and Agriculture:
2030 Organic Strategy - National Strategy for 30 % Organic
Food and Farming by 2030,
https://www.bmel.de/EN/topics/farming/organic-farming/2030-organic-strategy.html)
- ENDS
-
For
further information contact:
Eden
Research plc
|
www.edenresearch.com
|
Sean Smith
Alex Abrey
|
01285 359
555
|
|
|
Cavendish Capital Markets Limited (Nominated advisor and
broker)
|
|
Giles Balleny / George
Lawson (Corporate Finance)
Charlie Combe (Broking)
Michael Johnson (Sales)
|
020 7397
8900
|
|
|
Hawthorn Advisors (Financial PR)
|
|
Victoria Ainsworth
|
eden@hawthornadvisors.com
|
Notes to Editors:
Eden Research is the
only UK-listed company focused on biopesticides for
sustainable agriculture. It develops and supplies innovative
biopesticide products and natural microencapsulation technologies
to the global crop protection, animal health and consumer products
industries.
Eden's products are formulated with
terpene active ingredients, based on natural plant defence
metabolites. To date, they have been primarily used on high-value
fruits and vegetables, improving crop yields and marketability,
with equal or better performance when compared with conventional
pesticides. Eden has three products currently on the
market:
Based on plant-derived active
ingredients, Mevalone® is a foliar biofungicide which
initially targets a key disease affecting grapes and other
high-value fruit and vegetable crops. It is a useful
tool in crop defence programmes and is aligned with the
requirements of integrated pest management programmes. It is
approved for sale in a number of key countries whilst Eden and its
partners pursue regulatory clearance in new territories thereby
growing Eden's addressable market globally.
Cedroz™ is a
bionematicide that targets free living nematodes which are
parasitic worms that affect a wide range of high-value fruit and
vegetable crops globally. Cedroz is registered for sale on
two continents and Eden's commercial collaborator, Eastman
Chemical, is pursuing registration and commercialisation of this
important new product in numerous countries globally.
Eden's seed treatment
product, EcovelexÔ was developed to safely tackle crop destruction caused
by birds - a major cause of losses in maize and other
crops. Ecovelex works by creating an unpleasant taste or odour
that repels birds, leaving the seeds safely intact and the birds
unaffected and free to find alternative food sources. The
product is based on Eden's plant-derived chemistry, registered in
the EU, U.S. and elsewhere, and formulated using Eden's Sustaine®
microencapsulation system.
Eden's Sustaine® encapsulation
technology is used to harness the biocidal efficacy of naturally
occurring chemicals produced by plants (terpenes) and can also be
used with both natural and synthetic compounds to enhance their
performance and ease-of-use. Sustaine microcapsules are
naturally-derived, plastic-free, biodegradable micro-spheres
derived from yeast. It is one of the only viable, proven and
immediately registerable solutions to the microplastics problem in
formulations requiring encapsulation.
Eden was admitted to trading on AIM
on 11 May 2012 and trades under the symbol EDEN. It was
awarded the London Stock Exchange Green Economy Mark in January
2021, which recognises London-listed companies that derive
over 50% of their total annual revenue from products and services
that contribute to the global green economy. Eden derives 100% of
its total annual revenues from sustainable products and
services.
For more information about Eden,
please visit: www.edenresearch.com.